These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 7772251)
1. SV40 T antigen directed by a powerful erythroid enhancer-promoter produced sarcomas and pancreatic tumors but not erythroid-specific tumors in transgenic mice. Teitz T; Yen TS; Chang JC; Kan YW DNA Cell Biol; 1994 Jul; 13(7):705-10. PubMed ID: 7772251 [TBL] [Abstract][Full Text] [Related]
2. Amplification of a SV40 T antigen transgene is associated with sarcomagenesis in mice. Teitz T; Yen TS; Kan YW Carcinogenesis; 1994 Sep; 15(9):2049-51. PubMed ID: 7923601 [TBL] [Abstract][Full Text] [Related]
3. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas. Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690 [TBL] [Abstract][Full Text] [Related]
4. Unexpected and coordinated expression of Spi-1, Fli-1, and megakaryocytic genes in four Epo-dependent cell lines established from transgenic mice displaying erythroid-specific expression of a thermosensitive SV40 T antigen. Starck J; Mouchiroud G; Gonnet C; Mehlen A; Aubert D; Dorier A; Godet J; Morlé F Exp Hematol; 1999 Apr; 27(4):630-41. PubMed ID: 10210321 [TBL] [Abstract][Full Text] [Related]
5. Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene. Teitz T; Chang JC; Kitamura M; Yen TS; Kan YW Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2910-4. PubMed ID: 7681991 [TBL] [Abstract][Full Text] [Related]
6. Thymic epithelial neoplasms in transgenic mice expressing SV40 T antigen under the control of an erythroid-specific enhancer. Teitz T; Chang JC; Kan YW; Yen TS J Pathol; 1995 Nov; 177(3):309-15. PubMed ID: 8551394 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous sarcomas of probable neuronal origin in a transgenic mouse strain containing an albumin promoter-fused simian virus 40 large T antigen gene. Kawabuchi B; Nomura K; Ohtake K; Hino O; Aizawa S; Machinami R; Kitagawa T Jpn J Cancer Res; 1994 Jun; 85(6):601-9. PubMed ID: 8063613 [TBL] [Abstract][Full Text] [Related]
8. Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice. Nogues N; Magnan E; De Grandis P; Butz M; Kineman RD; Kopchick JJ; Frohman LA Mol Cell Endocrinol; 1998 Feb; 137(2):161-8. PubMed ID: 9605518 [TBL] [Abstract][Full Text] [Related]
9. Development of neuroepithelial tumors of the adrenal medulla in transgenic mice expressing a mouse hypothalamic growth hormone-releasing hormone promoter-simian virus-40 T-antigen fusion gene. Pecori Giraldi F; Mizobuchi M; Horowitz ZD; Downs TR; Aleppo G; Kier A; Wagner T; Yun JS; Kopchick JJ; Frohman LA Endocrinology; 1994 Mar; 134(3):1219-24. PubMed ID: 8119162 [TBL] [Abstract][Full Text] [Related]
10. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals. Santarelli R; Tzeng YJ; Zimmermann C; Guhl E; Graessmann A Oncogene; 1996 Feb; 12(3):495-505. PubMed ID: 8637705 [TBL] [Abstract][Full Text] [Related]
11. Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase-related protein 1/SV40 T antigen transgenic mice. Penna D; Schmidt A; Beermann F Oncogene; 1998 Nov; 17(20):2601-7. PubMed ID: 9840923 [TBL] [Abstract][Full Text] [Related]
12. Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen. Theuring F; Götz W; Balling R; Korf HW; Schulze F; Herken R; Gruss P Oncogene; 1990 Feb; 5(2):225-32. PubMed ID: 2157185 [TBL] [Abstract][Full Text] [Related]
13. Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen. Marcus DM; Lasudry JG; Carpenter JL; Windle J; Howes KA; al-Ubaidi MR; Baehr W; Overbeek PA; Font RL; Albert DM Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):392-6. PubMed ID: 8603844 [TBL] [Abstract][Full Text] [Related]
14. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice. Gordon J; Del Valle L; Otte J; Khalili K Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901 [TBL] [Abstract][Full Text] [Related]
15. Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes. Sola C; Tronik D; Dreyfus M; Babinet C; Rougeon F Oncogene Res; 1989; 5(2):149-53. PubMed ID: 2558335 [TBL] [Abstract][Full Text] [Related]
16. Haploid male germ cells show no susceptibility to transformation by simian virus 40 large tumour antigen in transgenic mice. Nayernia K; Samani AA; Klaproth S; Engel W Cell Biol Int; 1998; 22(6):437-43. PubMed ID: 10328852 [TBL] [Abstract][Full Text] [Related]
17. Smooth muscle and bone neoplasms in transgenic mice expressing SV40 T antigen. Wilkie TM; Schmidt RA; Baetscher M; Messing A Oncogene; 1994 Oct; 9(10):2889-95. PubMed ID: 8084593 [TBL] [Abstract][Full Text] [Related]
18. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene. Bell RH; Memoli VA; Longnecker DS Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183 [TBL] [Abstract][Full Text] [Related]
19. Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice. Perez-Stable C; Altman NH; Brown J; Harbison M; Cray C; Roos BA Lab Invest; 1996 Feb; 74(2):363-73. PubMed ID: 8780156 [TBL] [Abstract][Full Text] [Related]
20. Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen. Soldevila G; Geiger T; Flavell RA J Immunol; 1995 Dec; 155(12):5590-600. PubMed ID: 7499842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]